Author Archive: Jessica Torres

Jessica Torres

Jessica is a Marketing & Web Content Coordinator in the Business Development department at BIO. She keeps all the content for the Business Development conference event web pages up to date, optimizes email marketing campaigns to increase open and click-through rates, and leverages emerging social media tools to increase engagement among attendees at industry conferences and events. After a long day of marketing and social media, she goes home and blogs about marketing and social media on her personal website www.getstuckintraffic.com, and on Twitter.

Latest Posts

Find Your Next Asia Partnership in Tokyo at BIO Asia

Asia2013_115x76_Thumbnail copy

On April 8-9, 2014, the BIO Asia International Conference will enter its eleventh year. This year, biopharma industry leaders will convene at the Grand Hyatt in Tokyo, Japan to make the cross border deals that will advance collaboration between Asia and the West. This event has become the premier customized partnering event for Western and Asian biopharma executives. According to JP Morgan healthcare specialist Scott Braunstein, Japan has become one of the most critical markets for pharma Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

What’s New in RNAi Therapeutics?

87881842

At the 16th Annual BIO CEO & Investor Conference​, Monday morning’s therapeutic workshop, “Delivering the (RNAi) Goods,” featured a panel discussion moderated by Thomas Wei, senior research analyst at Jeffries LLC. The panel gave investors a peek into the novel approaches utilized by four leading companies in this area: Dicerna Pharmaceuticals, Arrowhead Research Corporation, Alnylam Pharmaceuticals, and Regulus Therapeutics. RNAi therapeutics, which include gene silencing, exon skipping, and mircroRNA therapy, are a promising area in the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

What’s In Store for Biotechs at this Year’s CEO & Investor Conference

CEO2014_blog copy

In just a few weeks, industry leaders will gather in New York for one of BIO’s largest and most successful events, the 16th Annual BIO CEO & Investor Conference. As we’ve seen at JPMorgan, the extraordinary performance of biotech equities for the past several years has generated a great deal of interest among investors to work with biotech companies to foster innovation in the coming year. This year’s event is shaping up to be even Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

BIO One-On-One Partnering Kicks Off!

Joe Colangelo

Partnering kicked off this today at the Business Forum at the 2013 BIO International Convention, and the numbers so far show that we have a strong week ahead of us. Over 130,000 partnering meeting requests have been requested Almost 22,000 meetings are already scheduled 4,900 of those meetings are exhibitor partnering meetings For a more in-depth look at the types of companies being represented at and stats on how many partnering meetings are taking place, check out this interview with Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Session Summary: What Every CEO Must Know About IP In Biotech

Biotech Boot Camp

On Sunday, April 21st, 2013, I attended a standing room only session titled, “What Every CEO Must Know About IP In Biotech”, part of Day One of Entrepreneurship Boot Camp. Kathryn Doyle, Ph.D., J.D., of Riverside Law and Stephan Sammut of the Wharton School spoke about changing patent laws and what they mean for biotech companies. Concepts and tips discussed included: How to develop a patent strategy when developing a product you’re trying to commercialize When Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,